Lenvatinib is an oral tyrosine kinase inhibitor. It very well may be found available under the brand name Lenvima. Lenvatinib has been endorsed for use in separated thyroid disease https://medium.com/@rulebreakersquaddd/an-outline-of-the-expense-of-lenvatinib-b7905103cf85